Expression and activities analysis of a fusion protein CREKA/tTF
- VernacularTitle:CREKA/tTF融合蛋白表达及活性鉴定
- Author:
Yi SU
;
Jianghua YAN
;
Shengyu WANG
;
Jie HE
;
Min YE
- Publication Type:Journal Article
- Keywords:
CREKA;
tTF;
tumor;
target of vasculature;
fusion protein
- From:
Chinese Journal of Biochemical Pharmaceutics
2010;31(2):94-97
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To prepare a novel fusion protein of CREKA and tTF as a universal carrier targeting to cancer,and to analyze its activities.Methods CREKA and tTF gene were acquired by PCR,and inserted into plasmid pET22b(+)to construct recombinant plasmid CREKA/tTF/pET22b(+),and the fusion gene was expressed in E.coli BL21.The fusion protein Wag purified through Nickel-affinity chromatography column.After purifying,the fusion protein was refold by subsequent dialysis.The activities of the fusion proteins were measured by coagulation timing and quantitative fluorescence test in vitro.Results The recombinant plasmid CREKA/tTF/pET22b(+)with correct sequence was obtained.The fusion protein was highly expressed in E.coli BL21.The coagulation of the fusion protein Was determined by the coagulation test.And the capability of the fusion protein effectively binding to clotted plasma proteins is identified in quantitative fluorescence test.Conclusion The recombinant plasmid CREKA/tTF/pET22b(+)with correct sequence was built.The fusion protein CREKA/tTF with both TF and CREKA activity was successfully obtained.
